Cargando…

Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients

Glioblastomas (GBMs) are characterized by four subtypes, proneural (PN), neural, classical, and mesenchymal (MES) GBMs, and they all have distinct activated signaling pathways. Among the subtypes, PN and MES GBMs show mutually exclusive genetic signatures, and the MES phenotype is, in general, belie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Tuyen N. M., Oh, Jiwoong, Kim, Sohyun, Antonio, Jayson M., Vo, Vu T. A., Om, Jiyeon, Choi, Jong-Whan, Kim, Jeong-Yub, Jung, Chan-Woong, Park, Myung-Jin, Jeong, Yangsik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210935/ https://www.ncbi.nlm.nih.gov/pubmed/32280134 http://dx.doi.org/10.1038/s12276-020-0413-1

Ejemplares similares

Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment
por: Vo, Vu T. A., et al.
Publicado: (2022)

Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPARγ activation exerting cancer growth suppression
por: Hua, Tuyen N.M., et al.
Publicado: (2019)

Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2016)

Fluorescence/photoacoustic imaging-guided nanomaterials for highly efficient cancer theragnostic agent
por: Doan, Vu Hoang Minh, et al.
Publicado: (2021)

Emodin coupled with high LET neutron beam—a novel approach to treat on glioblastoma
por: Kim, Jeong-Yub, et al.
Publicado: (2022)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017)

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2019)

Author Correction: Fluorescence/photoacoustic imaging-guided nanomaterials for highly efficient cancer theragnostic agent
por: Doan, Vu Hoang Minh, et al.
Publicado: (2021)

Interaction of curcumin with glioblastoma cells via high and low linear energy transfer radiation therapy inducing radiosensitization effects
por: Kim, Jeong-Yub, et al.
Publicado: (2022)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Shifting emphasis from pharmacogenomics to theragnostics
por: Ozdemir, Vural, et al.
Publicado: (2006)

Bacteriophages as Solid Tumor Theragnostic Agents
por: Veeranarayanan, Srivani, et al.
Publicado: (2021)

Molecular Imaging and Theragnostics of Thyroid Cancers
por: Giovanella, Luca, et al.
Publicado: (2022)

Aptamers as Theragnostic Tools in Prostate Cancer
por: Cruz-Hernández, Carlos David, et al.
Publicado: (2022)

The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields
por: Kim, Yong-Seok, et al.
Publicado: (2018)

The potential of exosomes as theragnostics in various clinical situations
por: Kang, Ju-Seop
Publicado: (2020)

Personalisation of Molecular Radiotherapy through Optimisation of Theragnostics
por: Davis, LauraMay, et al.
Publicado: (2020)

Nuclear Medicine and Cancer Theragnostics: Basic Concepts
por: Zoi, Vasiliki, et al.
Publicado: (2023)

Theragnostic (64)Cu/(67)Cu Radioisotopes Production With RFT-30 Cyclotron
por: Lee, Jun Young, et al.
Publicado: (2022)

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications
por: Kang, Min Seok, et al.
Publicado: (2023)

Necrosis targeted combinational theragnostic approach to treat cancer
por: Ji, Yun, et al.
Publicado: (2014)

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer
por: Lee, Hak Jong, et al.
Publicado: (2016)

Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
por: Uthaman, Saji, et al.
Publicado: (2018)

Theragnostic potentials of core/shell mesoporous silica nanostructures
por: Ravindran Girija, Aswathy, et al.
Publicado: (2019)

What Is Known about Theragnostic Strategies in Colorectal Cancer
por: Parisi, Alessandro, et al.
Publicado: (2021)

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
por: Jans, Hans-S., et al.
Publicado: (2022)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

Microfluidic Fabrication of Gadolinium-Doped Hydroxyapatite for Theragnostic Applications
por: Somoza, Manuel, et al.
Publicado: (2023)

Metabolic Priming as a Tool in Redox and Mitochondrial Theragnostics
por: Pinho, Sónia A., et al.
Publicado: (2023)

Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma
por: Park, Hyung Kyu, et al.
Publicado: (2015)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)

Magnetic Dehydrodipeptide-Based Self-Assembled Hydrogels for Theragnostic Applications
por: Carvalho, André, et al.
Publicado: (2019)

Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis
por: Alphandéry, Edouard
Publicado: (2022)

Synthesis and Characterization of Magnetic Composite Theragnostics by Nano Spray Drying
por: Perecin, Caio José, et al.
Publicado: (2022)

Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022)

Photo-Functionalized Magnetic Nanoparticles as a Nanocarrier of Photodynamic Anticancer Agent for Biomedical Theragnostics
por: Nam, Ki Chang, et al.
Publicado: (2020)

Peroxisome Proliferator-Activated Receptor-Gamma Expression in the Lung Tissue of Obese Rats
por: Hwang, Su Jin, et al.
Publicado: (2011)

Aripiprazole sensitizes head and neck cancer cells to ionizing radiation by enhancing the production of reactive oxygen species
por: Jeong, Hyeon‐Jeong, et al.
Publicado: (2022)

Optimisation of clinical SPECT imaging with 155Tb for theragnostic radionuclide therapy
por: Cocolios, Thomas Elias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3nnsahbvm8ten19utbio5um1ei